Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)
Clinical trial NCT07741565 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07741565
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2031-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.